PATENT CLAIM ANALYSIS

Application Number: 16252158
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["424", "093210"]

Abstract:
Chimeric antigen receptors containing mesothelin antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.

Claim (Index 60):
The method of  claim 59 , wherein the CAR comprises an amino acid sequence of SEQ ID NO: 14, 16, or 18, or a sequence with 85%, 90%, 95%, 96%, 97%, 98% or 99% identity thereof.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.55
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15866222', '15767076', '16132064', '15511973', '15934770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8168241072818354
- 35 USC 102 Novelty (BERT): 0.6285911537741316
- Combined Prediction Score: 0.7980008119310651
- Mean Citation Score: 545.1284919999998
- Max Citation Score: 644.8046
- Similarity Product: 528.089897887516

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test